These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 1342645
1. In vitro postantibiotic effect of roxithromycin and erythromycin against gram-positive cocci. Chang JC, Hsueh PR, Young C. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):276-84. PubMed ID: 1342645 [Abstract] [Full Text] [Related]
2. Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria. Dornbusch K, Olofsson C, Holm S. APMIS; 1999 May; 107(5):505-13. PubMed ID: 10335955 [Abstract] [Full Text] [Related]
3. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens]. Nakashio S, Iwasawa H, Iino S, Shimada J. Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874 [Abstract] [Full Text] [Related]
4. [Antimicrobial activities of roxithromycin against recently obtained clinical isolates]. Igari J, Oguri T, Tachibana Y, Misawa N, Nakamura A, Shitara M, Umezu S, Nakamura Y, Tazawa S, Shimoura M, Ugajin K, Mori T, Shimada J, Kaku M, Murase M, Hirakata Y, Matsuda J. Jpn J Antibiot; 1997 Jul; 50(7):640-9. PubMed ID: 9743909 [Abstract] [Full Text] [Related]
5. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae. Kuenzi B, Segessenmann C, Gerber AU. J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426 [Abstract] [Full Text] [Related]
6. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope]. Yano H, Kobayashi T, Okitsu N, Aoki A, Toriya M, Nakada Y, Sagai H, Iyobe S, Inoue M. Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861 [Abstract] [Full Text] [Related]
7. [Antibiotic resistance of Gram-positive cocci isolated in 2008]. Dorobăţ OM, Bădicuţ I, Tălăpan D, Tenea C, Rafila A. Bacteriol Virusol Parazitol Epidemiol; 2010 Feb; 55(2):83-92. PubMed ID: 21553473 [Abstract] [Full Text] [Related]
9. In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci. Varotto F, Garlaschi ML, Garlaschi MC, Falchi M, Scaglione F, Cattaneo G, De Luca M, Fraschini F. J Chemother; 1990 Dec; 2(6):355-61. PubMed ID: 2093106 [Abstract] [Full Text] [Related]
10. In vitro activities of DX-619 and comparison quinolones against gram-positive cocci. Wickman PA, Black JA, Moland ES, Thomson KS. Antimicrob Agents Chemother; 2006 Jun; 50(6):2255-7. PubMed ID: 16723599 [Abstract] [Full Text] [Related]
11. [Susceptibility to roxithromycin of gram-positive cocci isolated from patients with lowered immunity]. Mróz E, Podolak-Dawidziak M, Grzybek-Hryncewicz K, Dworniczek E. Med Dosw Mikrobiol; 1994 Jun; 46(1-2):5-8. PubMed ID: 7967928 [Abstract] [Full Text] [Related]
12. The effect of roxithromycin on the virulence of gram-positive cocci. Gemmell CG, McLeod M. Diagn Microbiol Infect Dis; 1992 Jun; 15(4 Suppl):67S-70S. PubMed ID: 1617927 [Abstract] [Full Text] [Related]
13. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae]. Andreoni O. Minerva Med; 1983 Mar 24; 74(12):619-24. PubMed ID: 6339995 [Abstract] [Full Text] [Related]
14. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens. Noviello S, Ianniello F, Leone S, Esposito S. J Antimicrob Chemother; 2003 Nov 24; 52(5):869-72. PubMed ID: 14519672 [Abstract] [Full Text] [Related]
15. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria. Minguez F, Ramos C, Loscos A, Chiu ML, Prieto J. Chemotherapy; 1993 Nov 24; 39(3):163-8. PubMed ID: 8389685 [Abstract] [Full Text] [Related]
16. Susceptibility of Staphylococcus aureus, Streptococcus pyogenes and Diplococcus pneumoniae to antibiotics. Comparison of patterns in Poland and Federal Republic of Germany. Jeljaszewicz J, Stochmal I, Dajek Z, Pulverer G, Hryniewicz W, Cybulska J, Switalski LM, Dziarski R. Zentralbl Bakteriol Orig A; 1976 Aug 24; 235(4):376-85. PubMed ID: 10702 [Abstract] [Full Text] [Related]
17. The postantibiotic effect of fusidic acid against gram-positive bacteria. Munckhof WJ, Turnidge JD. J Antimicrob Chemother; 1997 Sep 24; 40(3):433-6. PubMed ID: 9338499 [Abstract] [Full Text] [Related]
18. In vitro activity of novel rifamycins against gram-positive clinical isolates. Murphy CK, Karginova E, Sahm D, Rothstein DM. J Antibiot (Tokyo); 2007 Sep 24; 60(9):572-6. PubMed ID: 17917240 [Abstract] [Full Text] [Related]
19. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. Odenholt-Tornqvist I, Löwdin E, Cars O. Antimicrob Agents Chemother; 1995 Jan 24; 39(1):221-6. PubMed ID: 7695310 [Abstract] [Full Text] [Related]
20. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus]. Rolin O, Bouanchaud DH. Pathol Biol (Paris); 1989 May 24; 37(5):375-7. PubMed ID: 2780094 [Abstract] [Full Text] [Related] Page: [Next] [New Search]